Raymond James Financial’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$159K Buy
15,303
+634
+4% +$7.08K ﹤0.01% 5094
2026
Q1
$175K Sell
14,669
-53
-0.4% -$542 ﹤0.01% 4915
2025
Q4
$147K Sell
14,722
-5,174
-26% -$49.4K ﹤0.01% 4857
2025
Q3
$178K Sell
19,896
-93,861
-83% -$869K ﹤0.01% 4655
2025
Q2
$1.07M Sell
113,757
-26
-0% -$229 ﹤0.01% 3534
2025
Q1
$1.23M Buy
113,783
+93,082
+450% +$937K ﹤0.01% 3332
2024
Q4
$197K Buy
+20,701
New +$210K ﹤0.01% 4409

Other funds holding AHCO

Raymond James Financial's AHCO Position: Q2 2026 in Review

Raymond James Financial increased its AdaptHealth (AHCO) stake by 4.3% in Q2 2026, buying an estimated $7.08K and bringing the position to 15,303 shares worth $159K. The position accounts for ﹤0.01% of the portfolio, ranked #5094.

Raymond James Financial first reported a position in AHCO in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.23M in Q1 2025. 239 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Raymond James Financial held 15,303 shares of AdaptHealth worth $159K as of Q2 2026.
  • Raymond James Financial bought 634 AdaptHealth shares in Q2 2026, an estimated $7.08K.
  • AdaptHealth made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #5094 holding.
  • Raymond James Financial first reported a position in AdaptHealth in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's AdaptHealth position peaked at $1.23M in Q1 2025.
  • 239 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.